ProfileGDS4718 / 204790_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 91% 83% 94% 92% 85% 75% 91% 96% 92% 95% 94% 85% 81% 84% 86% 93% 72% 77% 69% 89% 90% 92% 91% 88% 80% 95% 82% 93% 81% 77% 78% 94% 94% 79% 69% 83% 90% 95% 82% 92% 84% 91% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8850688
GSM549102patient 115, normal, homogenized [OPG study]9.2544191
GSM549104patient 119, normal, homogenized [OPG study]8.2688783
GSM549108patient 138, normal, homogenized [OPG study]9.8751194
GSM549119patient 077, normal, homogenized [OPG study]9.6164492
GSM549133patient 032, cancer, homogenized [OPG study]8.5643385
GSM549139patient 042, cancer, homogenized [OPG study]7.3239875
GSM549099patient 107, normal, homogenized [OPG study]9.3963391
GSM549109patient 139, normal, homogenized [OPG study]10.693896
GSM549110patient 046, normal, homogenized [OPG study]9.6949892
GSM549114patient 063, normal, homogenized [OPG study]10.521195
GSM549122patient 082, normal, homogenized [OPG study]9.9100194
GSM549134patient 033, cancer, homogenized [OPG study]8.5022685
GSM549136patient 036, cancer, homogenized [OPG study]8.1048481
GSM549140patient 044, cancer, homogenized [OPG study]8.3750784
GSM549111patient 047, normal, homogenized [OPG study]8.6174186
GSM549113patient 057, normal, homogenized [OPG study]10.051693
GSM549132patient 031, cancer, homogenized [OPG study]7.0993972
GSM549137patient 038, cancer, homogenized [OPG study]7.5522277
GSM549142patient 047, cancer, homogenized [OPG study]6.7821469
GSM549100patient 110, normal, homogenized [OPG study]9.0334889
GSM549107patient 135, normal, homogenized [OPG study]9.3106590
GSM549115patient 068, normal, homogenized [OPG study]9.8424792
GSM549116patient 072, normal, homogenized [OPG study]9.4051991
GSM549120patient 078, normal, homogenized [OPG study]8.9015888
GSM549131patient 030, cancer, homogenized [OPG study]7.9256980
GSM549118patient 074, normal, homogenized [OPG study]10.281795
GSM549129patient 027, cancer, homogenized [OPG study]8.0700482
GSM549123patient 088, normal, homogenized [OPG study]9.8938593
GSM549124patient 006, cancer, homogenized [OPG study]7.8489781
GSM549126patient 015, cancer, homogenized [OPG study]7.5524177
GSM549128patient 025, cancer, homogenized [OPG study]7.714878
GSM549103patient 117, normal, homogenized [OPG study]9.9736294
GSM549117patient 073, normal, homogenized [OPG study]10.103494
GSM549138patient 041, cancer, homogenized [OPG study]7.7836579
GSM549141patient 045, cancer, homogenized [OPG study]6.8753569
GSM549130patient 028, cancer, homogenized [OPG study]8.1487283
GSM549101patient 111, normal, homogenized [OPG study]9.1025290
GSM549105patient 128, normal, homogenized [OPG study]10.180495
GSM549106patient 134, normal, homogenized [OPG study]8.2542182
GSM549112patient 048, normal, homogenized [OPG study]9.5523992
GSM549125patient 011, cancer, homogenized [OPG study]8.2658184
GSM549127patient 024, cancer, homogenized [OPG study]9.3148691
GSM549135patient 035, cancer, homogenized [OPG study]8.9361288